| Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ... Cancer discovery 8 (1), 37-48, 2018 | 277 | 2018 |
| A UGT1A1 genotype‐guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies MR Sharma, SS Joshi, TG Karrison, K Allen, G Suh, R Marsh, MF Kozloff, ... Cancer 125 (10), 1629-1636, 2019 | 31 | 2019 |
| Evaluation of the association of perioperative UGT1A1 genotype–dosed gFOLFIRINOX with margin-negative resection rates and pathologic response grades among patients with locally … DVT Catenacci, L Chase, S Lomnicki, T Karrison, R de Wilton Marsh, ... JAMA Network Open 3 (2), e1921290-e1921290, 2020 | 28 | 2020 |
| Clinical activity of olaparib in urothelial bladder cancer with DNA damage response gene mutations RF Sweis, B Heiss, J Segal, L Ritterhouse, S Kadri, JE Churpek, K Allen, ... JCO precision oncology 2, 1-7, 2018 | 21 | 2018 |
| Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II precision medicine trial (NCT02213289). SS Joshi, SB Maron, S Lomnicki, BN Polite, M Sharma, J Ibe, K Allen, ... Journal of Clinical Oncology 36 (4_suppl), TPS198-TPS198, 2018 | 11 | 2018 |
| FOLFIRINOX as first-line therapy in patients with metastatic gastroesophageal cancers (GEC). AC Lockhart, KA Krajewski, A Wang-Gillam, M Amin, S Sorscher, KH Lim, ... Journal of Clinical Oncology 33 (3_suppl), 177-177, 2015 | 6 | 2015 |
| A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies. M Sharma, DVT Catenacci, T Karrison, K Allen, JD Peterson, RW Marsh, ... Journal of Clinical Oncology 32 (15_suppl), 4125-4125, 2014 | 4 | 2014 |
| A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies. M Sharma, DVT Catenacci, T Karrison, A Ganjoo, K Allen, GK Suh, ... Journal of Clinical Oncology 35 (4_suppl), 427-427, 2017 | 2 | 2017 |
